0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > UBE1

UBE1

Brief Information

Name:Ubiquitin-like modifier-activating enzyme 1
Target Synonym:EC:6.2.1.45,UBE1,Ubiquitin-Activating Enzyme E1 (A1S9T And BN75 Temperature Sensitivity Complementing),UBA1, Ubiquitin-Activating Enzyme E1 Homolog (Yeast),POC20 Centriolar Protein Homolog (Chlamydomonas),Ubiquitin-Like Modifier Activating Enzyme 1,Testicular Secretory Protein Li 63,EC 6.2.1.45,CFAP124,AMCX1,POC20,SMAX2,UBA1A,UBE1X,A1S9,A1ST,GXP1,Ubiquitin-activating enzyme E1,Protein A1S9,A1S9T,Ubiquitin-like modifier-activating enzyme 1,UBA1,Ubiquitin Like Modifier Activating Enzyme 1,A1S9T An
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
UB1-H5248 Human Human UBE1 / UBA1 Protein, His Tag
UB1-H5248-structure
UB1-H5248-sds
ACRO Quality

Synonym Name

A1S9T and BN75 temperature sensitivity complementing,A1S9T,A1ST,AMCX1,GXP1,MGC4781,POC20 centriolar protein homolog,POC20,Protein A1S9,SMAX2,UBA1,UBA1, ubiquitin-activating enzyme E1 homolog A,UBA1A,UBE1,UBE1A1S9,UBE1X,ubiquitin-activating enzyme E1 (A1S9

Background

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TAK-243 TAK-243; MLN-7243 Phase 1 Clinical Takeda Pharmaceutical Co Ltd Solid tumours; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken